Looking to publish in Autoimmunity? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginAutoimmunity is an international peer-reviewed journal publishing research on cell and molecular immunology, immunogenetics, and molecular biology relevant to immunity and autoimmunity. Its scope includes innate lymphoid cells, T cells, B cells, molecular mediators of the immune system, regulatory mechanisms of T-cell and antibody responses, and epigenetic and metabolic processes, as well as systemic and organ-specific autoimmune responses and immune disorders. The journal converted to a full Open Access journal from Volume 56 (2023), while previous volumes remain available through a Pay to Read model.
Looking to publish in Autoimmunity? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Autoimmunity accepts the following article types. Click on an article type to view submission instructions.
Research Articles
Review Articles
Brief Reports
Recent Publications
Transcription factor 12 promotes acute myeloid leukemia cell survival by regulating mitochondrial function and ROS
Nianxue Wang, Jianhong Xie, Ruya Zhang, Can Yang, Wei Ren, Liping Shu
Stage-specific ROMO1 in rheumatoid arthritis: predictive immune insights into the MIF pathway and HLA-DR/IL2RA axis via integrated GWAS, transcriptomic, single-cell, and spatial profiling
Tailin Wang, Jingsong Zhao, Long Xu, Qian He
Androgen-associated remodeling of pulmonary NK cells and sex-biased susceptibility in lupus-associated diffuse alveolar hemorrhage
Lifang Wen, Xin Luo, Xiaoyun Chen, Li Jiang, Meiling Zheng, Changxing Gao, Ming Zhao
Zinc finger protein 24 enhances the pro-inflammatory activities of Tc17 cells and Tc17.1 cells in mouse collagen-induced arthritis
Song Zhang, Xieqing Du, Pu Yang, Yanbo Zhou, Zhigang Liu, Haiqing Hu
The m6A reader IGF2BP2 promotes proinflammatory signaling in Lupus nephritis by recognizing STAT1 m6A modifications
ChangZhi Zheng, XianMei Xu, Di Wu, Run Cheng, YouWei Bai, DeGuang Wang
Frequently asked questions
How long does it take to publish?
6 days avg. from submission to first decision; 64 days avg. from submission to first post-review decision; 29 days avg. from acceptance to online publication.
Reformat to Autoimmunity using Livewrite PremiumWhat are the publication costs?
Standard APC: $3565 / £2640 / EUR 3170 / AUD 4960, plus VAT or other local taxes where applicable. No submission charge.
Reformat to Autoimmunity using Livewrite Premium